Showing Results for
- Academic Journals (21)
Search Results
- 21
Academic Journals
- 21
- 1
- 2
- 3From:Oncogene (Vol. 35, Issue 9) Peer-ReviewedCorrection to: Oncogene advance online publication 6 July 2015; doi:10.1038/onc.2015.169 Since the online publication of this article the authors noticed an error in one of the authors' names. 'G Ciliberto' was...
- 4
- 5
- 6
- 7From:Scandinavian Journal of Medicine and Science in Sports (Vol. 30, Issue 2) Peer-ReviewedAbstract Only
- 8From:Oncogene (Vol. 35, Issue 9) Peer-ReviewedErbB3, a member of the ErbB family of receptor tyrosine kinases, is a potent activator of phosphatidyl inositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) signaling, driving tumor cell survival and...
- 9
- 10
- 11
- 12From:Oncogene (Vol. 35, Issue 9) Peer-ReviewedOncogene (2016) 35, 1206; doi:10.1038/onc.2015.418 Correction to: Oncogene (2016) 35, 1143-1152; doi:10.1038/onc. 2015.169;published online 6 July 2015 Since the online publication of this article the authors...
- 13
- 14
- 15From:Journal of Veterinary Pharmacology and Therapeutics (Vol. 34, Issue 3) Peer-ReviewedAbstract Only
- 16
- 17From:Archives of Disease in Childhood (Vol. 89, Issue 4) Peer-ReviewedBarth syndrome (BTHS) is an X linked disorder characterised by cardiac and skeletal myopathy, severe and cyclical neutropenia, early growth retardation, and excessive excretion of urinary organic acids (notably...
- 18
- 19From:Oncogene (Vol. 35, Issue 9) Peer-ReviewedErbB3, a member of the ErbB family of receptor tyrosine kinases, is a potent activator of phosphatidyl inositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) signaling, driving tumor cell survival and...
- 20